Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > One Month
View:
Post by Ingiboy on Nov 15, 2023 11:39am

One Month

Tomorrow it will be one month since the Arbitration judgement was released.  Surely by now they have decided what comes next.  Replicel management always seems to come dangerously close to breaking CSA rules regarding releasing material information.  Something must be going on one way or another. After 2 years of waiting for the Arbitration judgement in total silence we now have this. I find it totally disrespectful to the small retail shareholders.
Most of us have been reasonably patient as this never ending process has played out but I think most of us have had enough.
Comment by Ingiboy on Nov 20, 2023 10:57am
 As we drift into our 6th week from the Arbitration announcement without hearing anything from the management of this company regarding the future there seems to be no answers. At the least they could give us some idea of what they are working on.  Would that be too much to ask?
Replicel Life Sciences Inc